Steven Watts

770 total citations
20 papers, 607 citations indexed

About

Steven Watts is a scholar working on Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, Steven Watts has authored 20 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Psychiatry and Mental health and 6 papers in Clinical Psychology. Recurrent topics in Steven Watts's work include Sexual function and dysfunction studies (11 papers), Hormonal and reproductive studies (8 papers) and Sexuality, Behavior, and Technology (6 papers). Steven Watts is often cited by papers focused on Sexual function and dysfunction studies (11 papers), Hormonal and reproductive studies (8 papers) and Sexuality, Behavior, and Technology (6 papers). Steven Watts collaborates with scholars based in United States, Canada and Japan. Steven Watts's co-authors include Lars Viktrup, Fredric J. Cohen, Coen Netelenbos, Peter Kenemans, Coen D.A. Stehouwer, Velja Mijatovic, G.W. de Valk-de Roo, Cornelis Kluft, Piet Meijer and David A. Cox and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, The Journal of Urology and European Urology.

In The Last Decade

Steven Watts

20 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven Watts United States	13	332	243	199	174	72	20	607
Jintai Luo China	15	104 0.3×	166 0.7×	91 0.5×	17 0.1×	62 0.9×	26	528
L.R. Bégin Canada	15	137 0.4×	117 0.5×	62 0.3×	46 0.3×	153 2.1×	32	732
Tim Hillard United Kingdom	11	351 1.1×	22 0.1×	34 0.2×	352 2.0×	80 1.1×	31	760
N. H. Cho South Korea	7	125 0.4×	85 0.3×	46 0.2×	33 0.2×	6 0.1×	10	647
Marilyn McIlwain United States	7	101 0.3×	52 0.2×	106 0.5×	46 0.3×	113 1.6×	8	560
W.D. Dunsmuir United Kingdom	11	65 0.2×	102 0.4×	246 1.2×	88 0.5×	155 2.2×	18	581
J. Placer Spain	16	106 0.3×	31 0.1×	221 1.1×	24 0.1×	175 2.4×	65	785
Luigi Rolle Italy	17	117 0.4×	356 1.5×	199 1.0×	24 0.1×	93 1.3×	51	833
Fuxun Zhang China	13	118 0.4×	82 0.3×	35 0.2×	36 0.2×	59 0.8×	54	521
Edward F. Ikeguchi United States	12	115 0.3×	192 0.8×	334 1.7×	29 0.2×	265 3.7×	19	873

Countries citing papers authored by Steven Watts

Since Specialization

Citations

This map shows the geographic impact of Steven Watts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Watts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Watts more than expected).

Fields of papers citing papers by Steven Watts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Watts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Watts. The network helps show where Steven Watts may publish in the future.

Co-authorship network of co-authors of Steven Watts

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Watts. A scholar is included among the top collaborators of Steven Watts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Watts. Steven Watts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Watts, Steven, et al.. (2025). TFEB-mediated proinflammatory response in murine macrophages induced by acute Alpha7 nicotinic receptor activation. Journal of Leukocyte Biology. 117(6). 1 indexed citations

Petri, Michelle, Steven Watts, Richard E. Higgs, & Matthew D. Linnik. (2021). Sub-setting systemic lupus erythematosus by combined molecular phenotypes defines divergent populations in two phase III randomized trials. Lara D. Veeken. 60(11). 5390–5396. 1 indexed citations

Reich, Kristian, Amy M. DeLozier, Fabio P. Nunes, et al.. (2020). Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials. Journal of Dermatological Treatment. 33(3). 1521–1530. 30 indexed citations

Kalunian, Kenneth, Murray B. Urowitz, David Isenberg, et al.. (2017). Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index. Lara D. Veeken. 57(1). 125–133. 11 indexed citations

Giuliano, François, Matthias Oelke, A. Jungwirth, et al.. (2013). Tadalafil Once Daily Improves Ejaculatory Function, Erectile Function, and Sexual Satisfaction in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia and Erectile Dysfunction: Results from a Randomized, Placebo- and Tamsulosin-Controlled, 12-Week Double-Blind Study. The Journal of Sexual Medicine. 10(3). 857–865. 52 indexed citations

Porst, Hartmut, Matthias Oelke, Evan R. Goldfischer, et al.. (2013). Efficacy and Safety of Tadalafil 5 mg Once Daily for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Subgroup Analyses of Pooled Data From 4 Multinational, Randomized, Placebo-controlled Clinical Studies. Urology. 82(3). 667–673. 45 indexed citations

Brock, Gerald, Kevin T. McVary, Claus G. Roehrborn, et al.. (2013). Direct Effects of Tadalafil on Lower Urinary Tract Symptoms versus Indirect Effects Mediated through Erectile Dysfunction Symptom Improvement: Integrated Data Analyses from 4 Placebo Controlled Clinical Studies. The Journal of Urology. 191(2). 405–411. 25 indexed citations

Paduch, Darius A., et al.. (2013). Effects of 12 weeks of tadalafil treatment on ejaculatory and orgasmic dysfunction and sexual satisfaction in patients with mild to severe erectile dysfunction: integrated analysis of 17 placebo‐controlled studies. British Journal of Urology. 111(2). 334–343. 15 indexed citations

Paduch, Darius A., Alexander Bolyakov, Anthony Beardsworth, & Steven Watts. (2011). Factors associated with ejaculatory and orgasmic dysfunction in men with erectile dysfunction: analysis of clinical trials involving the phosphodiesterase type 5 inhibitor tadalafil. British Journal of Urology. 109(7). 1060–1067. 15 indexed citations

10.

Broderick, Gregory A., Gerald Brock, Claus G. Roehrborn, et al.. (2010). Effects of Tadalafil on Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men With or Without Erectile Dysfunction. Urology. 75(6). 1452–1457. 56 indexed citations

11.

Brock, Gerald, Sidney Glina, Ignacio Moncada, et al.. (2009). Likelihood of Tadalafil-associated Adverse Events in Integrated Multiclinical Trial Database: Classification Tree Analysis in Men With Erectile Dysfunction. Urology. 73(4). 756–761. 9 indexed citations

12.

Donatucci, Craig F., David G. Wong, François Giuliano, et al.. (2008). Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option. Current Medical Research and Opinion. 24(12). 3383–3392. 33 indexed citations

13.

Hellstrom, Wayne J.G., Marc Gittelman, Jonathan P. Jarow, et al.. (2007). An Evaluation of Semen Characteristics in Men 45 Years of Age or Older after Daily Dosing with Tadalafil 20mg: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, 9-Month Study. European Urology. 53(5). 1058–1065. 44 indexed citations

14.

Nagao, Kōichi, Yasusuke Kimoto, Ken Marumo, et al.. (2006). Efficacy and safety of tadalafil 5, 10, and 20 mg in Japanese men with erectile dysfunction: Results of a multicenter, randomized, double-blind, placebo-controlled study. Urology. 68(4). 845–851. 19 indexed citations

15.

Marumo, Ken, et al.. (2006). A Comparison of the Efficacy and Tolerability of Tadalafil 10 mg and 20 mg in Japanese Patients with Severe Erectile Dysfunction. The Journal of Sexual Medicine. 4(3). 745–752. 7 indexed citations

16.

Jolly, E., Nina H. Bjarnason, Patrick Neven, et al.. (2003). Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years. Menopause The Journal of The North American Menopause Society. 10(4). 337–344. 85 indexed citations

17.

Sarkar, Somnath, et al.. (2002). Bridging Data between Two Ethnic Populations. A New Application of Matched Case-Control Methodology. Drug Information Journal. 36(2). 349–356. 3 indexed citations

18.

Cohen, Fredric J., et al.. (2000). Uterine Effects of 3-Year Raloxifene Therapy in Postmenopausal Women Younger Than Age 60. Obstetrics and Gynecology. 95(1). 104–110. 13 indexed citations

19.

Roo, G.W. de Valk-de, Coen D.A. Stehouwer, Piet Meijer, et al.. (1999). Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal Women. Arteriosclerosis Thrombosis and Vascular Biology. 19(12). 2993–3000. 139 indexed citations

20.

Cohen, Fredric J., et al.. (1998). P-86. Vaginal Complaints in Healthy Postmenopausal Women. Menopause The Journal of The North American Menopause Society. 5(4). 283–283. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact